EcoDrugPlus

Glutamate Receptor, Ionotropic, Ampa 3b

Ensembl ID : ENSIPUG00000016359
Gene Symbol: GRIA3B
3 Cross references
191 Possible Orthologues:

Glutamate Receptor, Ionotropic, Ampa 4b

Ensembl ID : ENSIPUG00000002027
Gene Symbol: GRIA4B
4 Cross references
252 Possible Orthologues:

Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 1a

Ensembl ID : ENSIPUG00000013467
Gene Symbol: GRIN1A
4 Cross references
206 Possible Orthologues:

Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 1b

Ensembl ID : ENSIPUG00000020724
Gene Symbol: GRIN1B
3 Cross references
151 Possible Orthologues:

Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 2a, A

Ensembl ID : ENSIPUG00000014570
Gene Symbol: GRIN2AA
3 Cross references
229 Possible Orthologues:

Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 2b, Genome Duplicate B

Ensembl ID : ENSIPUG00000021387
Gene Symbol: GRIN2BB
3 Cross references
251 Possible Orthologues:

Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 2ca

Ensembl ID : ENSIPUG00000005977
Gene Symbol: GRIN2CA
3 Cross references
115 Possible Orthologues:

Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 2d, A

Ensembl ID : ENSIPUG00000008957
Gene Symbol: GRIN2DA
2 Cross references
214 Possible Orthologues:

Glutamate Receptor, Ionotropic, N-Methyl-D-Aspartate 3bb

Ensembl ID : ENSIPUG00000013729
Gene Symbol: GRIN3BB
3 Cross references
222 Possible Orthologues:

Glutamate Receptor, Ionotropic, Kainate 5

Ensembl ID : ENSIPUG00000006049
Gene Symbol: GRIK5
3 Cross references
232 Possible Orthologues:

Glutamate Receptor, Metabotropic 2a

Ensembl ID : ENSIPUG00000018803
Gene Symbol: GRM2A
3 Cross references
207 Possible Orthologues:

Glutamate Receptor, Metabotropic 2b

Ensembl ID : ENSIPUG00000021899
Gene Symbol: GRM2B
4 Cross references
206 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).